Tag Archive for: MSD

Syntethic macrocyclic peptid compared with a typical small molecule drugUnnatural Products Inc
Partnership

Argenx and Unnatural Products ink US$1.5bn macrocycle deal

California oral macrocyclic peptide specialist Unnatural Products, Inc. and Dutch-Belgian Argenx SE have formed a multi-target research collaboration aimed at developing oral macrocyclic peptide drugs with UNP’s synthetic macrocycle platform.

Read more
Fundus in diabetis retinopathy. © By Shaofeng Hao, Changyan Liu, Na Li, Yanrong Wu, Dongdong Li, Qingyue Gao, Ziyou Yuan, Guanyan Li, Huilin Li, Jianzhou Yang, and Shengfu Fan. - (2022). - wikipedia.org/PLoS One (doi:10.1371/journal.pone.0275983.
acquisition

MSD grabs Eyebiotech Ltd for US$1.3bn upfront

US pharma giant Merck Sharp & Dohme (MSD) is decided to acquire London-based ophtalmology expert Eyebiotech Ltd for upt to US$3bn., US$1.7bn in future milestones.

Read more